Group Testing for Severe Acute Respiratory Syndrome– Coronavirus 2 to Enable Rapid Scale-up of Testing and Real-Time Surveillance of Incidence

Abstract High-throughput molecular testing for severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) may be enabled by group testing in which pools of specimens are screened, and individual specimens tested only after a pool tests positive. Several laboratories have recently published examples of pooling strategies applied to SARS-CoV-2 specimens, but overall guidance on efficient pooling strategies is lacking. Therefore we developed a model of the efficiency and accuracy of specimen pooling algorithms based on available data on SAR-CoV-2 viral dynamics. For a fixed number of tests, we estimate that programs using group testing could screen 2–20 times as many specimens compared with individual testing, increase the total number of true positive infections identified, and improve the positive predictive value of results. We compare outcomes that may be expected in different testing situations and provide general recommendations for group testing implementation. A free, publicly-available Web calculator is provided to help inform laboratory decisions on SARS-CoV-2 pooling algorithms.

[1]  Yael Mandel-Gutfreund,et al.  Evaluation of COVID-19 RT-qPCR test in multi-sample pools , 2020, medRxiv.

[2]  M. Busch,et al.  A generalizable method for estimating duration of HIV infections using clinical testing history and HIV test results , 2019, AIDS.

[3]  Guohong Deng,et al.  Viral Kinetics and Antibody Responses in Patients with COVID-19 , 2020, medRxiv.

[4]  William C Miller,et al.  Detection of acute infections during HIV testing in North Carolina. , 2005, The New England journal of medicine.

[5]  Hendrik Streeck,et al.  Ad hoc laboratory-based surveillance of SARS-CoV-2 by real-time RT-PCR using minipools of RNA prepared from routine respiratory samples , 2020, Journal of Clinical Virology.

[6]  H. Dai,et al.  Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19 , 2020, International Journal of Infectious Diseases.

[7]  Lei Liu,et al.  Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 , 2020, medRxiv.

[8]  Christopher D. Pilcher,et al.  Optimizing Screening for Acute Human Immunodeficiency Virus Infection with Pooled Nucleic Acid Amplification Tests , 2008, Journal of Clinical Microbiology.

[9]  Michael P Busch,et al.  Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection , 2003, AIDS.

[10]  P. Vollmar,et al.  Virological assessment of hospitalized patients with COVID-2019 , 2020, Nature.

[11]  A. Saah,et al.  Sensitivity and Specificity Reconsidered: The Meaning of These Terms in Analytical and Diagnostic Settings , 1997, Annals of Internal Medicine.

[12]  O. Tsang,et al.  Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study , 2020, The Lancet Infectious Diseases.

[13]  Malik Peiris,et al.  Viral dynamics in mild and severe cases of COVID-19 , 2020, The Lancet Infectious Diseases.

[14]  Lei Liu,et al.  Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 , 2020, medRxiv.

[15]  S. Hinrichs,et al.  Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources , 2020, American journal of clinical pathology.

[16]  Moran Yassour,et al.  Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection , 2020, Clinical Microbiology and Infection.

[17]  Quanyi Wang,et al.  Viral load of SARS-CoV-2 in clinical samples , 2020, The Lancet Infectious Diseases.

[18]  B. Pinsky,et al.  Sample Pooling as a Strategy to Detect Community Transmission of SARS-CoV-2. , 2020, JAMA.